Rare Disease

Rare disease studies require special services as patients are scarce, typically reside great distances from their research institutions, and have significant caregiver involvement.

The ClinOne platform is ideally suited to significantly improve patient study experience, enable remote participation, reduce risk, assist with travel challenges, and provide cost saving measures through technology.

Improve Enrollment Through Specialist Referrals

MD Referral | Traditional recruitment methods typically underperform, especially in rare disease studies with limited patient pools. ClinOne enhances your efforts by communicating directly with global specialists and physicians in our proprietary network who are located nearby your clinical sites and may have eligible patients to refer. ClinOne helps rare disease sponsors find and connect with physicians who are eager to find clinical trials as a care option for their patients.

Prepare Sites with Few Patients for Success

Engage & Interact | Low enrolling studies create risk to site staff as they are less familiar with study details, given the very few patients per site. ClinOne’s workflow management solution allows sites to follow detailed schedule of events specific to the protocol versions and amendments, reducing protocol errors by 50%.

Enable Remote Consent Before Patients Travel to Research Sites

eConsent | Rare diseases studies often require remote consents before traveling to research sites. ClinOne eConsent eliminates the risk of consents, sub-study consents and reconsents by providing streamlined consent technology and comprehensive audit log. ClinOne eConsent provides on-site and remote video consent capabilities to ensure timely consent opportunities and reduce unnecessary site visits. eConsent ensures patients and families understand the benefits and risks of the study so they can make an informed participation decision, which in turn supports increased compliance and retention, while minimizing or eliminating consent-related audit findings.

Help Patients and Families Manage Their Study Experience

Engage & Interact | No patient participates in an oncology trial alone. ClinOne’s platform provides a single BYOD solution for patients to review study information, share updates with family members and HCPs, and manage their trial activities including secure site communication, virtual and on-site visit scheduling using their own calendar, transportation with Uber Health, and telemedicine visits. ClinOne helps guide patients and families through a stressful and challenging time to monitor safety and progress in real time, improve compliance and reduce missed visit rate by 50%, and connect a personal care community – without getting in the way of their daily lives.

Improve Safety and Eliminate Unnecessary Site Visits

In rare disease studies, traveling for site visits often presents physical, safety, and financial hardships. ClinOne helps reduce the number of site visits, and makes it easier for patients and caregivers to navigate the process when in-person visits are required.

Connected Devices | Integrating objective and biometric data from convenient wearable sensors can improve safety monitoring (e.g. SPO2, fall detection, blood pressure) and provide real-world insight into activity, sleep, and other digital endpoints. Increasingly, regulatory authorities are reviewing these data to make labelling decisions and assess the true impact of your investigational treatment on patients. Ensure you have the complete picture of patient response with connected devices on the ClinOne platform.

Video Visits | Not all virtual visits are equal. ClinOne fully supports native face-to-face virtual visits including interaction with multiple people involved with a patient’s care, screen sharing for document and instruction review, and visual evaluations. Virtual visits improve safety while reducing potential missed on-site visits. Now that they are an essential component of any trial design, you need an experienced platform your patients and sites can trust.

Dosing Manager | When patients and caregivers are asked to administer medication at home, ClinOne’s dosing manager raises dosing compliance to industry leading compliance rates of 92% dosing compliance at 12-months on study. Patients can complete their dosing diary from personal devices, further increasing convenience and compliance.